An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
The protective human antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) focuses on the spike (S) protein, which decorates the virion surface and mediates cell binding and entry. Most SARS-CoV-2 protective antibodies target the receptor-binding domain or a single domina...
Main Authors: | Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, Kevin J. Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel S. Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin J. Doranz, Summer M. Diaz, Laura S. Handal, Robert H. Carnahan, Michael S. Diamond, Ivelin S. Georgiev, James E. Crowe Jr. |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-06-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI159062 |
Similar Items
-
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
by: Elaine C. Chen, et al.
Published: (2023-04-01) -
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
by: Elaine C. Chen, et al.
Published: (2021-08-01) -
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
by: Kevin J. Kramer, et al.
Published: (2021-10-01) -
A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.
by: Leslie Goo, et al.
Published: (2017-02-01) -
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape
by: Naveenchandra Suryadevara, et al.
Published: (2022-06-01)